PCQI Insights
PCQI Requirements vs Supplement Testimonial Claims on Social Media
Quick answer: a PCQI performs functions under preventive controls rules such as 21 CFR Part 117. That work does not decide whether supplement testimonial claims, social media posts or ads establish drug intended use. Dietary supplement operations also need a separate review of Part 111 and any Part 117 exemptions.
Confusion starts when a company treats every FDA issue as a preventive controls issue. Disease-related claims in testimonials, social media and other marketing materials raise intended-use and drug questions instead.
A PCQI’s role, by contrast, covers specified food safety plan activities when the preventive controls rule applies. This article looks at the marketing side: why customer stories and posts need their own review.
How Testimonials and Posts Can Signal Drug Intended Use
Under 21 U.S.C. 321(g)(1)(B), articles intended to diagnose, cure, mitigate, treat or prevent disease are drugs. Under 21 CFR 201.128, intended use is the objective intent of the persons legally responsible for the labeling of a product.
That intent may be shown by labeling claims, advertising matter, or oral or written statements by those persons or their representatives. So a testimonial that a company shares, or a post it publishes, can matter as much as the label.
In addition, 21 CFR 101.93(g) says FDA considers the context in which a statement is presented. Its disease-claim criteria include implied effects on a specific disease and the use of pictures, vignettes or symbols. For example, a shared story about relief from a named disease deserves the same scrutiny as a label claim.
Six Compliance Areas to Review
1. Identify the applicable FDA framework
Map the product and facility activities. Confirm whether Part 111 CGMP applies, and which Part 117 provisions apply or are exempt. Under 21 CFR 117.5(e), a supplement operation in compliance with Part 111 is exempt from Part 117 subparts C and G, so PCQI duties may not apply.
2. Keep hazard analysis within its purpose
Where it is required, use the hazard analysis to evaluate food safety hazards and preventive controls. It is not a substitute for assessing advertising and intended use.
3. Treat disease claims as a separate issue
Review claims about treating or preventing disease through a qualified regulatory process. Cover labels, websites, blogs, social media posts and testimonials.
4. Create a cross-functional escalation route
Give quality and operations teams a simple way to refer questionable promotional language to the right reviewers. Their job is to flag the issue, not to reach unsupported legal conclusions.
5. Keep clear and separate records
Store food safety plans and CGMP documents apart from claim approvals, content inventories and correction logs.
6. Reassess when products or claims change
Changes to the formula, use, target market or promotional statements can trigger different compliance obligations. Document each decision.
Supplement Testimonial Claims Review Checklist
✓ Confirm which regulatory requirements apply to the particular product and operation.
✓ Inventory the websites, labels, advertisements, social media posts, testimonials and other materials involved.
✓ Assign accountable reviewers, document decisions and control approved versions.
✓ Verify corrective actions across all affected channels and retain completion evidence.
Frequently Asked Questions
Does a PCQI approve dietary supplement disease claims?
No. PCQI responsibilities do not amount to FDA approval of marketing claims.
Are dietary supplements automatically subject to every Part 117 preventive control?
No. Applicability depends on the facility’s activities and on relevant exemptions or modified requirements.
Can a supplement become a drug based on its advertising?
It can. FDA may determine that disease treatment or prevention claims establish drug intended use. Advertising matter and written statements are among the evidence of intended use listed in 21 CFR 201.128.
PCQI Insights
Related Reading
PCQI Requirements vs FDA Dietary Supplement Disease Claims
Part 111 vs Part 117 scope, and who should decide whether a statement is a disease claim.
Read article →
PCQI vs. Dietary Supplement Website Claims
Why blogs and web pages that link to sales pages need claim review, not a PCQI sign-off.
Read article →
PCQI Requirements vs Dietary Supplement Marketing Claims
Keep preventive controls focused on hazards and work with claims reviewers.
Read article →
Need Help Managing Your PCQI Responsibilities?
Talk with our team about your PCQI responsibilities, products, operations and documentation priorities.
Independent educational content. PCQI Services is not affiliated with or endorsed by the U.S. Food and Drug Administration (FDA) or any company referenced in regulatory materials. This content is for general information only and does not constitute regulatory approval, certification or legal advice. Regulatory applicability must be assessed for each product, facility and operation. Read our terms.
